Location · Erie, PA
Clinical trials in Erie, PA
27 recruiting studies have a site in Erie, and 5 of them accept healthy volunteers.
27 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- Erie, PA + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Erie, PA + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo
- RecruitingHealthy volunteersPhase 3
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Pfizer
- Location
- Erie, PA + 10 other US sites
- Eligibility basics
- Ages 7+
- RecruitingPhase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular…
AbbVie
- Location
- Erie, PA + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1/Phase 2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sanofi
- Location
- Erie, PA + 30 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Location
- Erie, PA + 51 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Novartis Pharmaceuticals
- Location
- Erie, PA + 14 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
Genentech, Inc.
- Location
- Erie, PA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Eli Lilly and Company
- Location
- Erie, PA + 17 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Erie, PA + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 2/Phase 3
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Janssen Research & Development, LLC
- Location
- Erie, PA + 44 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Erie, PA + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Study in Adults With Geographic Atrophy
Sitala Bio LTD
- Location
- Erie, PA + 1 other US site
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Erie, PA + 11 other US sites
- Eligibility basics
- Ages 8–45
- RecruitingPhase 2
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
NexThera Co., Ltd.
- Location
- Erie, PA + 2 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Erie, PA + 55 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Inari Medical
- Location
- Erie, PA + 32 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Oculis
- Location
- Erie, PA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Kriya Therapeutics, Inc.
- Location
- Erie, PA + 2 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Kriya Therapeutics, Inc.
- Location
- Erie, PA
- Eligibility basics
- Ages 55–80
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Erie, PA + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Kodiak Sciences Inc
- Location
- Erie, PA + 47 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Kodiak Sciences Inc
- Location
- Erie, PA + 47 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Erie, PA + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only